May 10, 2017

Bavencio (avelumab) Injection is intended for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy, or who have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.

May 9, 2017
WRB will join Envoy Health Management as part of Diplomat’s offering of commercialization support services for manufacturers and biotech firms, among other service companies.
 
May 8, 2017

Executives from Celgene, Regeneron and Vertex represented the drug industry Monday during a biomedical research discussion, but drug prices, long a concern of President Donald Trump, were not discussed during the two-hour meeting.

May 8, 2017

Research of Mitsubishi Tanabe America drug showed individuals receiving edaravone declined less on a clinical assessment of daily functioning compared to those receiving a placebo.

May 5, 2017

The clinical-stage biopharmaceutical company listed 9.9 million shares at $17 per share on May 4. 

May 5, 2017

This announcement represents a major “step towards making some of the most expensive treatments for cancer more widely available in low- and middle-income countries,” the organization stated.

May 4, 2017

Total sales decline by 3% year over, but comparable-store stores improve by 1.2% year over year.

May 1, 2017
AmerisourceBergen said that 2016 revenue contribution from its existing agreement with Express Scripts was roughly $23 billion.
 
April 27, 2017

BioMarin Pharmaceuticals’ Brineura slows loss of walking ability (ambulation) in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.

April 27, 2017

The drug, manufactured by Bayer HealthCare Pharmaceuticals, is the first FDA-approved treatment for a liver cancer in almost a decade.

April 20, 2017

The drug is a once-daily oral maintenance treatment indicated to treat women with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.

April 18, 2017

Tecentriq (atezolizumab) was granted accelerated approval for the treatment of people with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin chemotherapy.

April 18, 2017

In fact, J&J stated is now including the estimated impact of the Actelion transaction in its financial guidance.

April 18, 2017

Beyond offering STI and HIV testing, Walgreens also is furthering its commitment to supporting communities impacted by HIV through prevention and early detection services, as well as HIV continuing education for its pharmacists. 

April 14, 2017

Jennifer Cretu — most recently VP marketing and public relations — has been named SVP pharma services and marketing.

April 14, 2017

Giant supermarket operator Kroger views health and wellness as an area for long-term investment, a point underscored by its purchase last year of specialty pharmacy ModernHEALTH.

April 14, 2017

Study’s senior author observed that the new approach would not only be more responsive to the most urgent unmet medical needs — terminal illnesses that are currently untreatable — it could also greatly accelerate the drug development process.

April 11, 2017

Atul Kavthekar has more than 20 years of experience in finance, most recently serving as CFO at e-retailer LivingSocial from June 2015 to December 2016. 

April 7, 2017

Dr. Regina Benjamin served as Surgeon General from 2009-2013 under Pres. Barack Obama.

April 6, 2017

Retailer seeing bottom-line improvement driven by sequential growth in retail pharmacy adjusted script comps, sequential progress in sales trends in its specialty pharmacy business, front store margin expansion and strong holiday seasonal category sales, said CEO Mike Bloom.

April 4, 2017

Accreditation shows ACS has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes.

April 3, 2017

The new alliance between Walgreens and PBM Prime Therapeutics will be led by Joel Wright as CEO. Another Walgreens veteran, Don Vidic, was named chief pharmacy and growth officer.

March 31, 2017

Retailer stated the loss of this contract does not affect the company’s 2017 financial results.

March 31, 2017

The company will be dispensing atopic dermatitis drug Dupixent (dupilumab) and the limited-distribution multiple sclerosis treatment Ocrevus (ocrelizumab).